Merck & Co., Inc. (MRK)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 125.78 |
| Open | 126.71 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's Range | 126.22 - 128.08 |
| 52 Week Range | 99.14 - 133.10 |
| Volume | |
| Avg. Volume | 8,327,698 |
| Market Cap | 321.543B |
| Beta (5Y Monthly) | 0.40 |
| PE Ratio (TTM) | 906.71 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 3.08 (2.43%) |
| Ex-Dividend Date | Mar 14, 2024 |
| 1y Target Est | N/A |
- Zacks
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda, when the company reports first-quarter 2024 earnings.
- Insider Monkey
10 Best Performing Biotech ETFs in 2024
In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just want to take a look at some more ETFs, go directly to the 5 Best Performing Biotech ETFs in 2024. Biotechnology is a challenging field, not ideal for […]
- Simply Wall St.
Merck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 78%
Key Insights Given the large stake in the stock by institutions, Merck's stock price might be vulnerable to their...
© 2024 Yahoo. All rights reserved.